All the known genes defective in patients with monogenic hypercholesterolemias are involved in the receptor-mediated uptake of low-density lipoproteins (LDL) by the LDL receptor (LDLR) in hepatocytes (22, 23). This evidence concerns the gene LDLR and Hypercholesterolemia.